ADial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Co.'s investigational new drug product, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. Co. has a license from the University of Virginia Patent Foundation to commercialize its AD04. The active pharmaceutical agent in AD04, Co.'s investigational new drug product, is ondansetron, which is also the active ingredient in Zofran®, an approval for nausea and vomiting post-operatively and after chemotherapy or radiation treatment and is commercially available in generic form. We show 25 historical shares outstanding datapoints in our ADIL shares outstanding history coverage, used to compute ADIL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ADIL market cap history over the course of time is important for investors
interested in comparing ADIL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ADIL versus a peer is one thing; comparing
ADIL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ADIL can fluctuate over the course of history.
With this page we aim to empower investors researching ADIL by allowing them to research the ADIL market cap history. |
Free ADIL Email Alerts:
Video: The Importance of Market Cap
